CN110973326A - 一种能够改善人体亚健康的压片糖果及其制备方法 - Google Patents
一种能够改善人体亚健康的压片糖果及其制备方法 Download PDFInfo
- Publication number
- CN110973326A CN110973326A CN201911265464.4A CN201911265464A CN110973326A CN 110973326 A CN110973326 A CN 110973326A CN 201911265464 A CN201911265464 A CN 201911265464A CN 110973326 A CN110973326 A CN 110973326A
- Authority
- CN
- China
- Prior art keywords
- parts
- health
- human body
- candy
- improving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 19
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims description 36
- 239000000463 material Substances 0.000 claims description 23
- 239000000843 powder Substances 0.000 claims description 18
- 229940026510 theanine Drugs 0.000 claims description 18
- 240000002853 Nelumbo nucifera Species 0.000 claims description 17
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 17
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 17
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 17
- 241000251511 Holothuroidea Species 0.000 claims description 13
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 11
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 11
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 11
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 9
- 235000008434 ginseng Nutrition 0.000 claims description 9
- 235000020717 hawthorn extract Nutrition 0.000 claims description 9
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 9
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 9
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 9
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 9
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 9
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 9
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 9
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 8
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 8
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 8
- 229930182490 saponin Natural products 0.000 claims description 8
- 150000007949 saponins Chemical class 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 238000007873 sieving Methods 0.000 claims description 7
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 6
- 235000021355 Stearic acid Nutrition 0.000 claims description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 6
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 6
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 6
- 239000008117 stearic acid Substances 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 229930182494 ginsenoside Natural products 0.000 claims description 3
- 229940089161 ginsenoside Drugs 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims description 2
- 240000004371 Panax ginseng Species 0.000 claims 3
- 241000965254 Apostichopus japonicus Species 0.000 claims 1
- 235000002789 Panax ginseng Nutrition 0.000 claims 1
- 239000008176 lyophilized powder Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 22
- 235000013305 food Nutrition 0.000 abstract description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
- 239000003814 drug Substances 0.000 abstract description 10
- 201000010099 disease Diseases 0.000 abstract description 9
- 239000000126 substance Substances 0.000 abstract description 8
- 230000009286 beneficial effect Effects 0.000 abstract description 6
- 239000000654 additive Substances 0.000 abstract description 2
- 230000000996 additive effect Effects 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 230000036541 health Effects 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 210000000056 organ Anatomy 0.000 description 11
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 210000005036 nerve Anatomy 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 210000004556 brain Anatomy 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 241000208340 Araliaceae Species 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 230000035790 physiological processes and functions Effects 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 235000019789 appetite Nutrition 0.000 description 5
- 230000036528 appetite Effects 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 229960003638 dopamine Drugs 0.000 description 5
- 230000029142 excretion Effects 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 239000013589 supplement Substances 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 206010000060 Abdominal distension Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 235000021152 breakfast Nutrition 0.000 description 4
- 230000001914 calming effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000007937 eating Effects 0.000 description 4
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 210000002569 neuron Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 241001092040 Crataegus Species 0.000 description 3
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 3
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 3
- 235000009685 Crataegus X maligna Nutrition 0.000 description 3
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 3
- 235000009486 Crataegus bullatus Nutrition 0.000 description 3
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 3
- 235000009682 Crataegus limnophila Nutrition 0.000 description 3
- 235000004423 Crataegus monogyna Nutrition 0.000 description 3
- 235000002313 Crataegus paludosa Nutrition 0.000 description 3
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 206010001497 Agitation Diseases 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 235000004879 dioscorea Nutrition 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000004213 low-fat Nutrition 0.000 description 2
- 238000005461 lubrication Methods 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 230000007102 metabolic function Effects 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000012260 Accidental injury Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010049976 Impatience Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000027288 circadian rhythm Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000002310 elbow joint Anatomy 0.000 description 1
- 229940124645 emergency medicine Drugs 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 230000009540 excitatory neurotransmission Effects 0.000 description 1
- 230000037080 exercise endurance Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 206010018388 glossodynia Diseases 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000007786 learning performance Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 208000018962 mouth sore Diseases 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000021238 nutrient digestion Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 210000004923 pancreatic tissue Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 210000000323 shoulder joint Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 201000010875 transient cerebral ischemia Diseases 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明涉及一种能够改善人体亚健康的压片糖果及其制备方法,所述的压片糖果包括主料和赋形剂制成,所述的主料为人参茎叶皂苷粉、海参肽、山药冻干粉、山楂提取物、茶氨酸和莲子提取物。本发明制备的压片糖果是一种综合性的食品,能够调节全身生理状况低下非疾病状态,是人们逐渐恢复正常的生理状健康的生活,通过各原料的特定配比制成,不添加任何药品、化学添加剂等成分,对于任何年龄人群不会产生副作用,携带方便,短时间对身体起到有益的作用。
Description
技术领域
本发明属于保健品技术领域,具体涉及一种能够改善人体亚健康的压片糖果及其制备方法。
背景技术
当今社会处于飞速发展的年代,人们无论生活环境、工作、家庭、经济,每天都处于沉重的压力之中,从青年到老年很多人身体长时间处于亚健康状态,游离在健康与疾病之间的状态,可以表现为浑身没劲,肌肉疼痛,关节不舒服,缺少润滑感,头晕,头痛,有的患者心脏会出现心慌、气短、胸闷、睡眠差,甚至经常失眠,饮食不振,不喜欢吃饭,腹隐痛出现腹泻、腹胀、便秘。男性会出现***减退、性生活不和谐。医院无法诊断为某种疾病,现实之中没有适合的药品调节整个身体的基本状态。
亚健康状态的人群,在我们生活之中非常普遍,因此在医学和营养学当中大部分采用补充营养物质,补充各类维生素稀有元素,补充蛋白质等营养物质或者安神安定对神经抑制作用,这种方法的效果甚微。
鉴于以上原因,特提出本发明。
发明内容
为了解决现有技术存在的以上问题,本发明提供了一种能够改善人体亚健康的压片糖果及其制备方法,本发明的糖果以促进人体的消化吸收恢复身体的正常新陈代谢为主,同时调整心血管生理功能,恢复胃肠道的正常代谢功能,调整神经内分泌恢复正常水平,补充人体所需要的微量元素。
为了实现上述目的,本发明采用如下技术方案:
一种能够改善人体亚健康的压片糖果,包括主料和赋形剂制成,所述的主料为人参茎叶皂苷粉、海参肽、山药冻干粉、山楂提取物、茶氨酸和莲子提取物。
进一步的,所述的主料与赋形剂的质量比为65-75:25-35。
进一步的,所述的主料与赋形剂的质量比为69:31。
进一步的,按照重量份,所述的主料包括人参茎叶皂苷粉400-410重量份、海参肽600-700重量份、山药冻干粉802-822重量份、山楂提取物950-1000重量份、茶氨酸540-590重量份和莲子提取物800-840重量份。
进一步的,按照重量份,所述的主料包括人参茎叶皂苷粉406.25重量份、海参肽650重量份、山药冻干粉812.5重量份、山楂提取物975重量份、茶氨酸568.75重量份和莲子提取物812.8重量份。
人参茎叶皂苷粉具有增强机体应激能力,调整内分泌或植物神经功能紊乱,抗疲劳,并具有增强心肌收缩力,提高心脏排血量的功能,可适用于冠状动脉粥样硬化性心脏病。
海参的作用:①能有效修复受损关节软骨,恢复骨关节的正常功能;②具有扩张血管,增加血液流量;抑制血小板聚集,增强纤维蛋白的溶解,改善微循环;促进炎症渗出物吸收;并有镇痛、镇静、抗炎、抗感染、提高机体免疫力的作用;③能够促进生长发育,缓解疲劳;④含有微量元素钒,能够使机体内铁元素更有效的吸收,改善各种贫血;⑤含有元素硒、锗等则具有清除人体自由基,防癌、抗癌的作用。
而针对我国血糖代谢异常人群的生理特点,中科院南海海洋研究所科研人员经多年努力攻关,在分子水平上截取海参多组蛋白,利用海参多组蛋白,多靶点、多途经修复糖尿病人受损的胰腺组织,实现血糖代谢异常的逆转。该研究成果已转化为:依安诺海参肽。保护心脑血管,海参含胆固醇低,脂肪含量相对少,是典型的高蛋白、低脂肪、低胆固醇事物,对高血压、冠心病、肝炎等病人及老年人堪称食疗佳品,常食对治病强身很有益处;提高免疫力;造血功能。
山药含有淀粉酶、多酚氧化酶、维生素B1等物质,有利于脾胃消化吸收功能,是一味平补脾胃的药食两用之品。不论脾阳亏或胃阴虚,皆可食用。临床上常用治脾胃虚弱、食少体倦、泄泻等病症。山药含有多种营养素,有强健机体,滋肾益精的作用。山药含有皂甙、黏液质,有润滑,滋润的作用,故可益肺气,养肺阴,治疗肺虚痰嗽久咳之症。山药含有粘液蛋白,有降低血糖的作用,可用于治疗糖尿病,是糖尿病人的食疗佳品。山药含有大量的黏液蛋白、维生素及微量元素,能有效阻止血脂在血管壁的沉淀,预防心血疾病,取得益志安神、延年益寿的功效。
山楂防治心血管疾病,降低血压和胆固醇、软化血管及利尿和镇静作用;开胃消食,特别对消肉食积滞作用更好,很多助消化的药中都采用了山楂;山楂有活血化淤的功效,有助于解除局部淤血状态,对跌打损伤有辅助疗效;山楂中有平喘化痰、抑制细菌、治疗腹痛腹泻的成分。
茶氨酸可以明显促进脑中枢多巴胺释放,提高脑内多巴胺生理活性。多巴胺是一种活化脑神经细胞的中枢神经递质,其生理活性与人的感情状态密切相关。茶氨酸显示出的降低高血压效果在一定程度上也可以被看作是一种安定作用。而这种安定作用则无疑会有助于身心疲劳的恢复;茶氨酸是茶叶中特有的游离氨基酸。茶叶中生津润甜的滋味就是它带来的。茶氨酸在新茶中最多,随发酵过程而减少。研究发现,茶氨酸可以明显促进脑中枢多巴胺释放,提高脑内多巴胺的生理活性。因此它能使人精神愉悦,同时会增强记忆,提高学***衡程度,并保持在适宜的水平上;茶氨酸在夜间会起到催眠作用,白天则发挥清醒作用;茶氨酸能抑制短暂脑缺血引起的神经细胞死亡,对神经细胞有保护作用。神经细胞的死亡与兴奋型神经传达物质谷氨酸有密切联系。在谷氨酸过多的情况下会出现细胞死,这通常是老年痴呆等症的病因。
莲子提取物含有丰富的蛋白质、脂肪和碳水化合物,莲子中的钙、磷和钾含量非常丰富,除可以构成骨骼和牙齿的成分外,还有促进凝血,使某些酶活化,维持神经传导性,镇静神经,维持肌肉的伸缩性和心跳的节律等作用。丰富的磷还是细胞的主要组成部分,帮助机体进行蛋白质、脂肪、糖类代谢,并维持酸碱平衡,对***的形成也有重要作用。莲子有养心安神的功效。中老年人特别是脑力劳动者经常食用,可以健脑,增强记忆力,提高工作效率并能预防老年性痴呆的发生。莲子心味道极苦,却有显著的强心作用,能扩张外周血管,降低血压。莲心还有很好的去心火的功效,治疗口舌生疮,助于睡眠。莲子有益心补肾、健脾止泻、固精安神的作用。
本发明的压片糖果主要针对食品中一些对人体有着营养和协调作用的成分进行生物化学提取,旨在改变人体的生理状态,现代医学已经由治疗疾病的***医学转变为改善人体健康细胞医学,其根本的核心技术在于根据临床症状调整病理状态,依据不同时期,不同环境,不同营养状况器官细胞功能状态,对人体器官细胞修复和改善。
本发明的压片糖果在改善人体亚健康状态,主要是通过以下两个方法,一是消化吸收器官营养物质的补充,人体器官若缺乏了消化营养物质的基本能力,人身体容易产生毒素,导致疾病的发生,例如高血压、高血脂、高血糖、通风等或癌症慢性疾病。二是可以增加人体功能性细胞的活跃,调整消化器官的兴奋性,例如消化不良,便秘、运动***骨关节机能衰退、心脑血管神经***,心脑血管肺栓塞等。本发明的压片糖果通过各原料的共同作用可以使人体从生理机能进行平衡和改善器官细胞营养,使人整体的新陈代谢功能有所加强,改善人体的亚健康状态。
进一步的,所述的赋形剂为羟丙基甲基纤维素、聚乙烯醇、硬脂酸和微晶纤维素。
进一步的,羟丙基甲基纤维素与微晶纤维素的质量比为950-1000:760-800。
进一步的,羟丙基甲基纤维素与微晶纤维素的质量比为15:12。
其中,赋形剂中的聚乙烯醇和硬脂酸的含量可根据情况酌情添加即可。
一种所述的能够改善人体亚健康的压片糖果的制备方法,包括如下步骤:
(1)按照各原料的重量分别称取备用;
(2)将备用的各原料进行混合均匀,制粒,过筛,压片,干燥,包衣,得到所述的压片糖果。
进一步的,步骤(2)中过筛为过8-12目筛,优选的,过10目筛。
进一步的,步骤(2)中干燥温度为50-60℃。
物料混合在原料容器(流化床)中呈环形流化状态,受到经过净化后加热空气预热和混合,将粘合剂溶液雾化喷入,使若干粒子聚集成含有粘结剂的团粒,由于热空气对物料的不断干燥,使团粒中水份蒸发,粘合剂凝固,此过程不断重复进行,形成理想的、均匀的多微孔球状颗粒。
本发明制备的压片糖果每片净含量为650毫克,服用方法及计量根据不同的人群进行调整,以下分为三种人群的情况进行解释说明。
第一组,调整消化吸收补充营养。
主要针对6-14岁青少年,60-75岁中老年,青少年突出表现在学习压力大,正在成长期。
中老年人群突出表现为人体器官逐渐衰老,功能下降,家庭操劳,这一组不同的两个群体亚健康人群比例很大。
早晚两餐每餐三粒与饭同时白水或汤吞服,30日后实验组人员改善***状态,便秘腹泻腹部胀气基本消失,食欲增强,睡眠有很大程度的改善。连续服用三至六个月,老年群体整体健康状况基本恢复生理状态,肩肘膝关节疼痛消失,身体轻松充满活力。
这两组群体应该适当的配合食品改善,基本上保证每天户外活动一至两个小时,控制高糖类食物,烟酒,浓茶,熬夜,保证足够饮水,排尿,吃饭。
第二组,调整生理期的生物节律变化。
主要是40岁至60岁中年男女,为更年期生理变化人群。35-50岁特殊环境人群,工作和生活压力过大,突出表现为生活不规律过劳和过累,严重的破坏了人体的生物节律,使人的生命受到威胁。这两个群体的共同特点是由于工作和生活环境,身体器官和激素的变化,工作条件情绪和社会矛盾的不断交替出现严重的影响人体的稳定生理代谢。
每日早餐后,服用四片本产品白,晚餐后服用四片,白水送下。连续服用六个月本发明的压片糖果。实验人员饮食,***各器官的生理功能都会有明显的改善,尤其心血管,******,会使人产生恢复青春的感觉,大脑增强记忆,工作和生活充满信心,建议间断性的长期服用。
这两组群体应该适当的配合食品改善,每天户外有氧运动一个小时慢走,骑自行车,游泳,特别要注意保证睡眠,适当的休息,睡眠和放松是人体恢复疲劳的最佳办法,定时定量的吃饭。
第三组,改善人体的免疫***。
人体的免疫***基本都是由遗传信息排列于下一代的模板之中,因遗传信息的改变要通过长期环境强力变化而变异,因此我们食物的作用通过消化吸收加强免疫各个器官的功能,尽量减少食品代谢中所产生的毒素。
这一组人群是健康衰弱的整体,无论是生理期内在激素的紊乱,还是外环境的给人们带来的压力和不稳性,还有环境的变化,意外的伤害。其实根本的原因主要是人体各器官的不协调和基本体质的营养缺乏,改善的方法,加强新陈代谢,调整营养消化和吸收。
连续服用本发明的压片糖果三个月,早晚各服用三片,大多数人的感觉是食欲旺盛,每日排便一至两次成条状,血脂血压基本稳定,全身肌肉和关节没有疼痛感,由于产品中各种维生素类和微量元素的不断的补充,改善了人体的各器官的功能状况。
建议这个实验组的人群间断性去的连续服用,直至身体健康恢复正常状态。这组群体应该适当的配合食品改善,加强运动,下午五点钟以后,参加体育锻炼,打乒乓球,打羽毛球,游泳,可以先健身运动。激发体内细胞的应激性以及荷尔蒙的分泌,使得细胞强烈的吸收,食品补充的各种维生素、蛋白质、脂肪、碳水化合物和矿物质,打开细胞间隙***通道,使得体内的毒素充分的排出,保护体内的免疫***,有强大的抵御疾病的能力。
与现有技术相比,本发明的有益效果为:
(1)本发明制备的压片糖果是一种综合性的食品,能够调节全身生理状况低下非疾病状态,是人们逐渐恢复正常的生理状健康的生活,通过各原料的特定配比制成,不添加任何药品、化学添加剂等成分,对于任何年龄人群不会产生副作用,携带方便,短时间对身体起到有益的作用;
(2)本发明的压片糖果主要改善因为消化吸收和***问题影响新陈代谢的基础生理功能,促进人体的消化吸收,恢复身体的正常新陈代谢为主,同时调整心血管生理功能,恢复胃肠道的正常代谢功能,调整神经内分泌恢复正常水平,补充人体所需要的微量元素,从而人体睡眠恢复到正常的生理要求,人体各阶段的生理周期为基础,进行全面的调整,一般经过三到六个月调理,大多数人恢复到正常水平。
具体实施方式
为使本发明的目的、技术方案和优点更加清楚,下面将对本发明的技术方案进行详细的描述。显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动的前提下所得到的所有其它实施方式,都属于本发明所保护的范围。
实施例1
本实施例的一种能够改善人体亚健康的压片糖果,包括主料和赋形剂制成,所述的主料与赋形剂的质量比为65:35,所述的主料包括人参茎叶皂苷粉400g、海参肽600g、山药冻干粉802g、山楂提取物950g、茶氨酸540g和莲子提取物800g,所述的赋形剂为羟丙基甲基纤维素950g、微晶纤维素为760g、硬脂酸200g和聚乙烯醇293g。
本实施例的能够改善人体亚健康的压片糖果的制备方法,包括如下步骤:
(1)按照各原料的重量分别称取备用;
(2)将备用的各原料进行混合均匀,制粒,过筛8目筛,压片,50℃干燥,包衣,得到所述的压片糖果。
实施例2
本实施例的一种能够改善人体亚健康的压片糖果,包括主料和赋形剂制成,所述的主料与赋形剂的质量比为69:31,所述的主料包括人参茎叶皂苷粉406.25g、海参肽650g、山药冻干粉812.5g、山楂提取物975g、茶氨酸568.75g和莲子提取物812.8g,所述的赋形剂为羟丙基甲基纤维素975g、微晶纤维素为780g、硬脂酸100g和聚乙烯醇43g。
本实施例的能够改善人体亚健康的压片糖果的制备方法,包括如下步骤:
(1)按照各原料的重量分别称取备用;
(2)将备用的各原料进行混合均匀,制粒,过筛10目筛,压片,55℃干燥,包衣,得到所述的压片糖果。
实施例3
本实施例的一种能够改善人体亚健康的压片糖果,包括主料和赋形剂制成,所述的主料与赋形剂的质量比为75:25,所述的主料包括人参茎叶皂苷粉410g、海参肽700g、山药冻干粉822g、山楂提取物1000g、茶氨酸590g和莲子提取物840g,所述的赋形剂为羟丙基甲基纤维素500g、微晶纤维素为400g、硬脂酸254g和聚乙烯醇300g。
本实施例的能够改善人体亚健康的压片糖果的制备方法,包括如下步骤:
(1)按照各原料的重量分别称取备用;
(2)将备用的各原料进行混合均匀,制粒,过筛12目筛,压片,60℃干燥,包衣,得到所述的压片糖果。
案例1
庞某,男,13岁,学生,根据学生家长反映,自幼和同年龄的孩子比较饭量小、食欲差、精神不集中、多动、个子矮小偏瘦型、运动缺乏耐力、气温变化容易感冒、学习成绩中下等、不愿参加集体活动。
经健康营养师建议,这个学生属于营养不良,青少年成长期,调整健康状态,补充营养,促进消化吸收。服用本实施例2制备的压片糖果,每日六片,早晚餐各三片,与饭食同步食用,食用一个月以后饭量增加、食欲增强。经过三个月的调整,班主任老师反应该学生上课精神集中,学习成绩有所提高、积极参加集体活动、运动耐力大幅度提高。
案例2
杨某某,女,54岁,机关干部,根据本人叙述,近五年自己感觉身体,体力,精力极度下降,突出表现便秘,失眠,经常做梦,血压,血糖,不稳定,食欲不佳,外界气候变化,关节有些隐痛。
经健康营养师建议,该女士为更年期综合症恢复期全面地进行健康调理,改善饮食和睡眠,加强室外运动,促进新陈代谢。服用本实施例1制备的压片糖果,早餐后一个小时服用三片,白水吞服,晚餐后一个小时服用四片,白水吞服,加强户外体育锻炼,每天25分钟左右,多食水果蔬菜。该女士40天以后,大便恢复正常,每天一至两次,食欲旺盛,每日睡眠可达六至八小时,食用该产品三个月以后,腰肩部的关节疼痛已经大幅度的减轻,血压,血脂基本稳定恢复到正常范围。
案例3
王某某,男,50岁,董事长,根据本人叙述,近两年市场管理严格。生产企业压力大,费用高,王先生长期处在,压力和紧张之中。吃不下饭睡不着觉,平时心跳过速,血压高,出虚汗,检查开会,迎来送往,业务应酬,精神崩溃,经常出现便秘和腹胀,有时候视力模糊。
经健康营养师建议:王先生一定要按照生理需要安排工作和生活,饮食起居要科学化,加强运动锻炼,对于消化***,心血管***,泌尿***,神经***,运动***进行综合性的调理。服用本实施例3制备的压片糖果,早餐和晚餐,饭后半小时每次四片白水吞服,非碳酸饮料天然苏打水,临睡前饮用150ml,夜间排尿后饮用150ml,早晨起床后,早饭前饮用150ml,造成胃液酸碱性环境促进本产品当中的微量元素和微生素的吸收,每天坚持户外活动或健身房运动40~60分钟。经过六个月的调整,身体健康整体有所改观,便秘腹胀,睡眠,饮食都已经恢复正常,血压血脂降到正常值,精神变得轻松了,食用本产品十二个月时,感觉到精力充沛,下午五点以后不再疲倦,已经放弃平时随身携带的降压药,止疼片等这些救急药物。以上所述,仅为本发明的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,可轻易想到变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应以所述权利要求的保护范围为准。
Claims (10)
1.一种能够改善人体亚健康的压片糖果,其特征在于,包括主料和赋形剂制成,所述的主料为人参茎叶皂苷粉、海参肽、山药冻干粉、山楂提取物、茶氨酸和莲子提取物。
2.根据权利要求1所述的能够改善人体亚健康的压片糖果,其特征在于,所述的主料与赋形剂的质量比为65-75:25-35。
3.根据权利要求1或2所述的能够改善人体亚健康的压片糖果,其特征在于,按照重量份,所述的主料包括人参茎叶皂苷粉400-410重量份、海参肽600-700重量份、山药冻干粉802-822重量份、山楂提取物950-1000重量份、茶氨酸540-590重量份和莲子提取物800-840重量份。
4.根据权利要求3所述的能够改善人体亚健康的压片糖果,其特征在于,按照重量份,所述的主料包括人参茎叶皂苷粉406.25重量份、海参肽650重量份、山药冻干粉812.5重量份、山楂提取物975重量份、茶氨酸568.75重量份和莲子提取物812.8重量份。
5.根据权利要求1所述的能够改善人体亚健康的压片糖果,其特征在于,所述的赋形剂为羟丙基甲基纤维素、聚乙烯醇、硬脂酸和微晶纤维素。
6.根据权利要求5所述的能够改善人体亚健康的压片糖果,其特征在于,羟丙基甲基纤维素与微晶纤维素的质量比为950-1000:760-800。
7.根据权利要求5所述的能够改善人体亚健康的压片糖果,其特征在于,羟丙基甲基纤维素与微晶纤维素的质量比为15:12。
8.一种权利要求1-7任意一项所述的能够改善人体亚健康的压片糖果的制备方法,其特征在于,包括如下步骤:
(1)按照各原料的重量分别称取备用;
(2)将备用的各原料进行混合均匀,制粒,过筛,压片,干燥,包衣,得到所述的压片糖果。
9.根据权利要求8所述的能够改善人体亚健康的压片糖果的制备方法,其特征在于,步骤(2)中过筛为过8-12目筛,优选的,过10目筛。
10.根据权利要求8所述的能够改善人体亚健康的压片糖果的制备方法,其特征在于,步骤(2)中干燥温度为50-60℃。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911265464.4A CN110973326A (zh) | 2019-12-11 | 2019-12-11 | 一种能够改善人体亚健康的压片糖果及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911265464.4A CN110973326A (zh) | 2019-12-11 | 2019-12-11 | 一种能够改善人体亚健康的压片糖果及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110973326A true CN110973326A (zh) | 2020-04-10 |
Family
ID=70092239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911265464.4A Pending CN110973326A (zh) | 2019-12-11 | 2019-12-11 | 一种能够改善人体亚健康的压片糖果及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110973326A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113068759A (zh) * | 2021-03-29 | 2021-07-06 | 刘玉华 | 一种清肺化痰止咳压片糖果及其制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1857116A (zh) * | 2005-12-20 | 2006-11-08 | 东莞广发制药有限公司 | 一种多功能健康食品及其制备方法与应用 |
WO2008065457A2 (en) * | 2006-11-29 | 2008-06-05 | Ante Juros | Herbal mixture with fraxinus, achillea and melissa to improve metabolism, boost immunity and help in therapy |
CN101700119A (zh) * | 2009-06-12 | 2010-05-05 | 李文金 | 改善成年人亚健康症状的口服剂 |
CN104643250A (zh) * | 2015-02-14 | 2015-05-27 | 河南省摇太阳食品有限公司 | 一种可双向调节体重改善亚健康的固体饮料 |
CN105266155A (zh) * | 2015-11-20 | 2016-01-27 | 延边利孚生物科技有限公司 | 用于改善脑亚健康的组合物及其制备方法 |
CN107801985A (zh) * | 2016-08-31 | 2018-03-16 | 江苏康缘药业股份有限公司 | 含山药、白扁豆、鸡内金、山楂的中药组合物及其应用 |
CN110367367A (zh) * | 2019-08-26 | 2019-10-25 | 刘玉华 | 一种使人深睡眠的压片糖果及其制备方法 |
-
2019
- 2019-12-11 CN CN201911265464.4A patent/CN110973326A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1857116A (zh) * | 2005-12-20 | 2006-11-08 | 东莞广发制药有限公司 | 一种多功能健康食品及其制备方法与应用 |
WO2008065457A2 (en) * | 2006-11-29 | 2008-06-05 | Ante Juros | Herbal mixture with fraxinus, achillea and melissa to improve metabolism, boost immunity and help in therapy |
CN101700119A (zh) * | 2009-06-12 | 2010-05-05 | 李文金 | 改善成年人亚健康症状的口服剂 |
CN104643250A (zh) * | 2015-02-14 | 2015-05-27 | 河南省摇太阳食品有限公司 | 一种可双向调节体重改善亚健康的固体饮料 |
CN105266155A (zh) * | 2015-11-20 | 2016-01-27 | 延边利孚生物科技有限公司 | 用于改善脑亚健康的组合物及其制备方法 |
CN107801985A (zh) * | 2016-08-31 | 2018-03-16 | 江苏康缘药业股份有限公司 | 含山药、白扁豆、鸡内金、山楂的中药组合物及其应用 |
CN110367367A (zh) * | 2019-08-26 | 2019-10-25 | 刘玉华 | 一种使人深睡眠的压片糖果及其制备方法 |
Non-Patent Citations (2)
Title |
---|
丛艳君等: "《活性蛋白质和肽的制备及在功能食品中的应用》", 30 April 2011, 中国轻工业出版社 * |
余海忠等: "《食品营养学概论》", 31 December 2018, 中国农业大学出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113068759A (zh) * | 2021-03-29 | 2021-07-06 | 刘玉华 | 一种清肺化痰止咳压片糖果及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101156685A (zh) | 营养保健粥 | |
CN104855956A (zh) | 失眠医学配方食品 | |
CN102823653A (zh) | 系列复方保健药膳奶片及其制备方法 | |
CN103169088A (zh) | 健脾养胃米及其制作方法 | |
CN111616364A (zh) | 一种红参阿胶饮品及其在保健饮品中的应用 | |
CN103416663A (zh) | 一种供糖尿病患者食用的五谷杂粮全营养配方食品 | |
CN104839669A (zh) | 抗衰老医学配方食品 | |
CN109820905A (zh) | 一种治疗失眠的药物组合物及其应用 | |
CN103461585B (zh) | 补气养生中药茶 | |
CN105233140A (zh) | 一种短梗五加健脾益胃功能的组合物及其制备方法 | |
CN101669624A (zh) | 一种具有改善妇女贫血功能的中药八宝茶及其制备方法 | |
CN104839659A (zh) | 气虚体质医学配方食品 | |
CN103704568B (zh) | 临床膳食食品 | |
CN105249440A (zh) | 一种阿胶糕 | |
CN105380073A (zh) | 一种糖尿病营养餐冲剂 | |
CN110973326A (zh) | 一种能够改善人体亚健康的压片糖果及其制备方法 | |
CN101991110B (zh) | 野生灵芝系列食品 | |
CN104489472A (zh) | 一种治疗消化不良、腹泻的食品 | |
CN104839671A (zh) | 壮阳医学配方食品 | |
CN108114222A (zh) | 一种补气健脾滋补肝肾的中药组合物及其制备方法 | |
CN101301084A (zh) | 一种儿童益智米的制造工艺 | |
KR102480311B1 (ko) | 체질 맞춤형의 학습 능력 증진용 건강 기능성 식품 조성물 제조방법 | |
CN107223955A (zh) | 具备养胃抗肿瘤功能的菌谷营养粉及其制备方法 | |
CN105077317A (zh) | 一种用于促进儿童增高的营养补充剂及其制备方法 | |
CN100488519C (zh) | 一种治疗痛经的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200410 |